BR100 Decreased By (-0.7%)
BR30 Decreased By (-1.82%)
KSE100 Decreased By (-0.44%)
KSE30 Decreased By (-0.72%)
AGHA 6.06 Increased By ▲ 0.01 (0.17%)
BECO 3.89 Increased By ▲ 0.06 (1.57%)
BML 56.71 Decreased By ▼ -1.62 (-2.78%)
BOP 28.18 Decreased By ▼ -0.17 (-0.6%)
CNERGY 12.42 Decreased By ▼ -1.22 (-8.94%)
CSIL 5.25 Increased By ▲ 0.04 (0.77%)
FCCL 53.21 Increased By ▲ 0.93 (1.78%)
FFL 12.79 Decreased By ▼ -0.11 (-0.85%)
FNEL 1.15 Increased By ▲ 0.02 (1.77%)
KEL 5.79 No Change ▼ 0.00 (0%)
KOSM 5.55 Increased By ▲ 0.04 (0.73%)
LOTCHEM 23.98 Increased By ▲ 0.09 (0.38%)
MLCF 91.61 Increased By ▲ 1.10 (1.22%)
NBP 159.03 Decreased By ▼ -0.69 (-0.43%)
NCPL 49.20 Decreased By ▼ -0.40 (-0.81%)
NPL 51.50 Decreased By ▼ -0.30 (-0.58%)
OGDC 307.95 Increased By ▲ 1.17 (0.38%)
PACE 9.21 Increased By ▲ 0.06 (0.66%)
PAEL 32.35 Increased By ▲ 0.02 (0.06%)
PIBTL 12.88 Decreased By ▼ -0.05 (-0.39%)
PPL 213.90 Decreased By ▼ -0.03 (-0.01%)
PRL 87.30 Decreased By ▼ -9.66 (-9.96%)
PTC 45.10 Decreased By ▼ -0.09 (-0.2%)
SSGC 22.40 Decreased By ▼ -0.13 (-0.58%)
TBL 9.06 Increased By ▲ 0.04 (0.44%)
TELE 6.52 Decreased By ▼ -0.20 (-2.98%)
TPL 25.81 Decreased By ▼ -0.10 (-0.39%)
TPLP 12.88 Increased By ▲ 0.28 (2.22%)
TREET 23.45 Decreased By ▼ -0.01 (-0.04%)
TRG 52.30 Increased By ▲ 0.34 (0.65%)
By

LONDON: Britain’s medicines regulator said Friday the Pfizer/BioNTech vaccine is safe for adolescents aged 12 to 15 after a “rigorous review”, following similar assessments in the European Union and United States.

The Medicines and Healthcare products Regulatory Agency (MHRA) approved the two-shot jab following clinical trials among younger age groups, saying the vaccine had met the “expected standards” of safety, quality and effectiveness.

A government committee on vaccination will now decide if and when to begin administering doses to the age bracket. So far it has promptly followed all MHRA rulings on vaccines offered by Pfizer and other companies.

Comments

Comments are closed for this article.